Aurora Cannabis Inc NYSE:ACB Given Average Recommendation of Hold by Analysts

aurora cannabis stock

That’s less than half the CA$50 million loss it incurred a year earlier. And the company said it found another CA$60 million to CA$80 million in annual costs that it can trim within 18 months. Among the groups of Nasdaq stocks in trouble this year are crypto names and marijuana stocks. When it comes to cryptos, Washington is clearly attacking the sector. Cannabis stocks have been in a major sell-off in the past few months as concerns about the industry remain.


This offering involved selling 70.4 million units for $2.45 per unit, with each unit including a 36-month warrant (exercise price of $3.20). ACB was able to achieve a 63% adjusted gross profit from Canadian medical sales in the latest quarter. Shares of ACB stock and other Canadian stocks can be purchased through an online brokerage account. A valuation method that multiplies the price of a company’s stock by the total number of outstanding shares.

Dow Jones Network

It can also be calculated by dividing the company’s Market Cap by the Net Profit. Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price. Aurora Cannabis’ stock was trading at C$1.25 on January 1st, 2023. Since then, ACB shares have decreased by 30.4% and is now trading at C$0.87.

booth and steve

Analysts have estimated the company’s revenue for the quarter at $48.21 million, with a low estimate of $43.39 million and a high estimate of $50 million. According to the average forecast, sales growth in current quarter could jump up 27.50%, compared to the corresponding quarter of last year. Wall Street analysts also predicted that in 2024, the company’s y-o-y revenues would reach $146.57 million, representing a decrease of -11.40% from the revenues reported in the last year’s results.

Since 1988 it has more than doubled the S&P 500 with an average gain of +24.52% per year. These returns cover a period from January 1, 1988 through February 6, 2023. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return.

Which Canadian Cannabis Company Will Be the Next Takeover Target?

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Morningstar’s Global Risk Model reveals how some of the app’s most popular stocks stack up on 11 different measures of equity-related risk. There’s plenty of opportunity for these stocks after a rough 2021. I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. In fact, the stock has fallen 78% over just the past 8 months since I covered the name and recommended focusing on the US operators. The 54% crash in May is small when considering that the company actually traded above $10 per share 1 year ago. Only 3 people have added Aurora Cannabis to their MarketBeat watchlist in the last 30 days.

Aurora Cannabis Stock in 2022: Skyrocket or Crash? – The Motley Fool

Aurora Cannabis Stock in 2022: Skyrocket or Crash?.

Posted: Fri, 28 Jan 2022 08:00:00 GMT [source]

An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. I don’t know if Aurora stock is necessarily going to crash in 2022. But given its current, highly unfavorable dynamics combined with the state of the pot industry in North America and abroad, I’d put my money on it continuing to head south rather than wafting higher in price. Shares of Aurora Cannabis rose 3.2% in early trading Tuesday after the company posted lower sales, but a smaller loss in the fourth quarter of 2021 than a year earlier. 2Two of the biggest players in the cannabis sector will be offering a glimpse of how well the industry is performing later this week when they reveal their latest earnings…

How big is Aurora Cannabis Inc?

Curaleaf is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks. CIBC reduced their price target on Aurora Cannabis from C$2.25 to C$1.75 in a research report on Monday, February 13th. Piper Sandler lowered their price target on Aurora Cannabis from $2.00 to $1.00 in a research note on Wednesday, December 28th.

EV / Sales ,09x EV / Sales ,78x Nbr of Employees Free-Float 87,9% More FinancialsCompanyAurora Cannabis Inc. is a Canada-based medical cannabis company. The Company’s adult-use brand portfolio includes Aurora Drift, San Rafael ’71, Daily Special, Whistler, Being and… That capital raise appeared to take some shareholders by surprise, as the company exited the quarter with $430 million in cash versus $334 million in debt. I note that subsequent to the quarter, the company repurchased $128 million of those convertible notes. Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations.

It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. While legal cannabis has not gone national yet, some cannabis companies hoping to up their brand profile by partnering with national brands. Consolidation is going to be the key theme among Canadian cannabis companies in 2023 and beyond. 52 week high is the highest price of a stock in the past 52 weeks, or one year.

ACB Aurora Cannabis Inc.Stock Price & Overview

There are currently 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should “hold” ACB shares. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system.

Meanwhile, there’s no reason to believe that scores of competitors will either consolidate, or drop out of the over-served Canadian market. Nor are the country’s consumers likely to shift away from the lower-margin recreational products they seem to favor. And a change in U.S. federal law that would allow pot imports, or a sudden explosion in medical marijuana legalization elsewhere abroad, are both pipe dreams for now. Meanwhile, since marijuana is still a Schedule 1 drug at the federal level in America, foreign companies can’t directly import product into this vast and highly tempting market. Outside of North America, available markets for foreign expansion are few and far between, and often consist of rather restrictive medical marijuana-only regimes . Aurora Cannabis is a Canadian vertically integrated cannabis producer and supplier.

According to the data, the short interest in Aurora Cannabis Inc. stood at 9.75% of shares outstanding as of Mar 14, 2023; the number of short shares registered in Feb 14, 2023 reached 29.57 million. The stock has fallen by -29.44% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ACB stock heading into the next quarter.

market share

The average rating score is and is based on 1 buy ratings, 2 hold ratings, and 1 sell ratings. The low in the last 52 weeks of Aurora Cannabis stock was 0.63. According to the current price, Aurora Cannabis is 101.52% away from the 52-week low. The high in the last 52 weeks of Aurora Cannabis stock was 3.69.


So, with the pressure mounting, Canadian cannabis executives think the industry is ripe for consolidation. And yesterday, Tilray CEO Irwin D. Simon stated as much on multiple occasions during the company’s 2023 fiscal third-quarter earnings call. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. ACB did see net revenues decline by 9% in the quarter due to price pressures across the portfolio. While the reported net loss was $1 billion, this included $923 million in impairment expenses. I estimate that excluding such non-cash losses, ACB generated a $58.7 million loss in the quarter.

  • Nor is there much in the way of progress to believe that things are improving.
  • Meanwhile, since marijuana is still a Schedule 1 drug at the federal level in America, foreign companies can’t directly import product into this vast and highly tempting market.
  • Announced today the closing of its previously announced bought deal offering of units of the Company …
  • Its current aim is to reach positive adjusted earnings before interest, taxes, depreciation, and amortization by the first half of 2023.

In 2020, Aurora performed a reverse split of its stock for the exact same reason. Shareholders, therefore, may welcome a different approach this time around. Finally, it could be tackling some of the long-standing issues with operational inefficiencies and overproduction of cannabis that have prevented it from being profitable. In May of this year, it closed a cultivation site in Canada, laying off 13% of its global workforce in the process and making progress toward scaling its output to be more in proportion to demand. As a result, management anticipates that it should have positive adjusted earnings before interest, taxes, depreciation, and amortization on an ongoing basis by the end of 2022.

Aurora And MedReleaf Australia Launch IndiMed Tempo 26, Expanding Product Offerings For Medical Cannabis Patients

6 equities research have issued 12 month price objectives for Aurora Cannabis’ stock. On average, they expect the company’s share price to reach $2.03 in the next twelve months. This suggests a possible upside of 216.1% from the stock’s current price.

If You Invested $10,000 In Aurora Cannabis’ IPO, This Is How Much … – The Motley Fool

If You Invested $10,000 In Aurora Cannabis’ IPO, This Is How Much ….

Posted: Sun, 21 Jun 2020 07:00:00 GMT [source]

Finally, Stifel Nicolaus lowered their price target on Aurora Cannabis from C$1.75 to C$1.45 in a research note on Friday, January 27th. At a minimum, I would wait for at least a couple of quarters’ worth of positive adjusted EBITDA and strong sales growth before even considering buying this pot stock. The company is in a much better place now, and its operations are much more sustainable. Over the trailing 12 months, Aurora has burned through CA$280 million.

Aurora canabiss stock has quite the ugly quarterly net loss streak going, and has managed to escape a nine-digit shortfall only once in the past five quarters . This is a summary of recent ratings for Aurora Cannabis and Curaleaf, as reported by Announces a new and unprecedented fall lineup of cannabis products. The Zacks Industry Rank assigns a rating to each of the 265 X Industries based on their average Zacks Rank. As an investor, you want to buy stocks with the highest probability of success.

Aurora Cannabis Repurchases ~$103 Million Principal Amount of … – PR Newswire

Aurora Cannabis Repurchases ~$103 Million Principal Amount of ….

Posted: Mon, 05 Dec 2022 08:00:00 GMT [source]

We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

If it maintained that rate, its cash balance could potentially fund its operations for nearly two years . That’s an important consideration for investors in a company that has normally been quick to raise money through stock issues. While having a significant chunk of cash on hand doesn’t guarantee that it won’t pursue further offerings in the near future, it could minimize the need to do so.

And fighting for market share is a surefire way to spend more money for each dollar of sales. The argument for why Aurora Cannabis stock could be a good investment starts with the growth of its top line and the increasing value of its brands. In the last five years, its quarterly revenue climbed by 327.2%, reaching $39.3 million, driven by its penetration of the Canadian recreational and medicinal markets. In the recreational cannabis market, it has brands positioned for everything from cheap flower to high-end vapes, concentrates, and even more exotic product formats like sublingual films. That means as consumer preferences develop, there’s a solid chance they’ll develop in a direction that’s building loyalty to one of the company’s product lines and shore up its base of revenue for years to come.

Leave a Reply